Last edition
News about "diabetes treatment"
Novo Nordisk Brings World's First Once-Weekly Basal Insulin Awiqli to India
Novo Nordisk India has launched Awiqli, the world's first once-weekly basal insulin, offering adults with diabetes a more convenient treatment option with fewer injections.
Diabetes Treatment | 10/07/2026 | By News Bureau | 185
The rise of GLP-1 therapies has transformed diabetes and obesity treatment. Following semaglutide patent expiry in India in March 2026, multiple companies entered the market simultaneously. Pharma Industrial India spoke with industry leaders about the opportunities, challenges, and future of this rapidly evolving therapeutic segment.
Diabetes Treatment | 26/06/2026 | By Akanki | 124
Dr. Reddy's Laboratories Wins Health Canada Nod for Generic Semaglutide Injection
Dr. Reddy's Laboratories secures Health Canada approval for generic semaglutide injection, becoming the first to gain market authorisation in Canada ahead of the review timeline.
Diabetes Treatment | 29/04/2026 | By News Bureau | 155
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy